Categories

Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

This Safety Communication describes the risk of false results, particularly false negative results, with the Curative SARS-Cov-2 test. Recommendations for patients, caregivers and health care professionals are provided.

http://www.fda.gov/medical-devices/safety-communications/risk-false-results-curative-sars-cov-2-test-covid-19-fda-safety-communication

 
Categories

Se activa inmunización contra covid-19 de grupo 5: mayores de 40 años podrán vacunarse a partir de este viernes

Se activa inmunización contra covid-19 de grupo 5: mayores de 40 años podrán vacunarse a partir de este viernes

Se activa inmunización contra covid-19 de grupo 5: mayores de 40 años podrán vacunarse a partir de este viernes13 de julio del 2021. Tomando en cuenta la llegada de la donación directa de vacunas contra la covid-19 por parte del gobierno de Estados Unidos...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2138-se-activa-inmunizacion-contra-covid-19-de-grupo-5-mayores-de-40-anos-podran-vacunarse-a-partir-de-este-viernes

 
Categories

Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene

Johnson & Johnson Consumer Inc. (JJCI) is voluntarily recalling all lots of five NEUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level. Internal testing identified low levels of benzene in some samples of the products. Consumers should stop using the affected products and fol

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/johnson-johnson-consumer-inc-issues-voluntary-recall-specific-neutrogenar-and-aveenor-aerosol

 
Categories

Nuevos ingresos hospitalarios por COVID-19 aumentan en 9.3%, a pesar de baja en hospitalizaciones totales

Nuevos ingresos hospitalarios por COVID-19 aumentan en 9.3%, a pesar de baja en hospitalizaciones totales

Nuevos ingresos hospitalarios por COVID-19 aumentan en 9.3%, a pesar de baja en hospitalizaciones totalesMartes 13 de julio, 2021. La semana epidemiológica 27 que abarcó del 4 al 10 de julio registró 9.237 casos de COVID-19...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2137-nuevos-ingresos-hospitalarios-por-covid-19-aumentan-en-9-3-a-pesar-de-baja-en-hospitalizaciones-totales

 
Categories

Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance

Innoveix Pharmaceuticals, Inc. is voluntarily recalling the following lots of sterile compounded drug products, within expiry. The products are being recalled due to a lack of assurance of sterility. These concerns arose following a routine inspection of the pharmacy by FDA.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/innoveix-pharmaceuticals-inc-issues-voluntary-recall-all-sterile-compounded-drug-products-due-lack-0